Acetyl-11-keto-β-boswellic acid suppresses docetaxel-resistant prostate cancer cells in vitro and in vivo by blocking Akt and Stat3 signaling, thus suppressing chemoresistant stem cell-like properties

Acetyl-11-keto-β-boswellic acid suppresses docetaxel-resistant prostate cancer cells in vitro and in vivo by blocking Akt and Stat3 signaling, thus suppressing chemoresistant stem cell-like propertiesAcetyl-11-keto-β-boswellic acid suppresses docetaxel-resistant prostate cancer cells in vitro and in vivo by blocking Akt and Stat3 signaling, thus suppressing chemoresistant stem cell-like properties, Published online: 31 August 2018; doi:10.1038/s41401-018-0157-9Acetyl-11-keto-β-boswellic acid suppresses docetaxel-resistant prostate cancer cells in vitro and in vivo by blocking Akt and Stat3 signaling, thus suppressing chemoresistant stem cell-like properties

Source: Acta Pharmacologica Sinica - August 31, 2018 Category: Drugs & Pharmacology Authors: Yong-qing Liu Shi-kang Wang Qing-qing Xu Hui-qing Yuan Yan-xia Guo Qian Wang Feng Kong Zhao-min Lin De-qing Sun Rong-mei Wang Hong-xiang Lou Source Type: research